ArticleJACC. CardioOncology2025

Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.

Claire Glen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.